Patents by Inventor Sandra M. Monaghan

Sandra M. Monaghan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Nicotinamide derivatives useful as PDE4 inhibitors
    Patent number: 7060717
    Abstract: The invention relates to nicotinamide derivatives and to processes for the preparation of, intermediates used in the preparation of, compositions containing and the uses of, such derivatives. The nicotinamide derivatives according to the present invention are useful in numerous diseases, disorders and conditions, in particular inflammatory, allergic, respiratory diseases, disorders and conditions, as well as wounds.
    Type: Grant
    Filed: June 9, 2004
    Date of Patent: June 13, 2006
    Assignee: Pfizer Inc
    Inventors: Simon Bailey, Elisabeth C. L. Gautier, Alan J. Henderson, Thomas V. Magee, Anthony Marfat, John P. Mathias, Dale G. McLeod, Sandra M. Monaghan, Blanda L. C. Stammen
  • Nicotinamide derivatives useful as PDE4 inhibitors
    Patent number: 6949573
    Abstract: The invention relates to nicotinamide derivatives and to processes for the preparation of, intermediates used in the preparation of, compositions containing and the uses of, such derivatives. The nicotinamide derivatives according to the present invention are useful in numerous diseases, disorders and conditions, in particular inflammatory, allergic, respiratory diseases, disorders and conditions, as well as wounds.
    Type: Grant
    Filed: February 6, 2003
    Date of Patent: September 27, 2005
    Assignee: Pfizer Inc
    Inventors: Simon Bailey, Elisabeth C. L. Gautier, Alan J. Henderson, Thomas V. Magee, Anthony Marfat, John P. Mathias, Dale G. McLeod, Sandra M. Monaghan, Blanda L. C. Stammen
  • Purine derivatives
    Patent number: 6900309
    Abstract: The present invention relates to compounds of the formula and pharmaceutically acceptable salts and solvates thereof, and to processes for the preparation of, intermediates used in the preparation of, compositions containing and the uses of, such compounds as adenosine A2a receptor agonists.
    Type: Grant
    Filed: June 8, 2000
    Date of Patent: May 31, 2005
    Assignee: Pfizer Inc
    Inventors: Simon J. Mantell, Sandra M. Monaghan
  • Nicotinamide derivatives useful as PDE4 inhibitors
    Publication number: 20040224975
    Abstract: The invention relates to nicotinamide derivatives and to processes for the preparation of, intermediates used in the preparation of, compositions containing and the uses of, such derivatives. The nicotinamide derivatives according to the present invention are useful in numerous diseases, disorders and conditions, in particular inflammatory, allergic, respiratory diseases, disorders and conditions, as well as wounds.
    Type: Application
    Filed: June 9, 2004
    Publication date: November 11, 2004
    Applicant: Pfizer Inc.
    Inventors: Simon Balley, Elisabeth C. L. Gautier, Alan J. Henderson, Thomas V. Magee, Anthony Marfat, John P. Mathias, Dale G. McLeod, Sandra M. Monaghan, Blanda L. C. Stammen
  • Nicotinamide derivatives and a tiotropium salt in combination for the treatment of diseases
    Publication number: 20030220361
    Abstract: The invention relates to a combination of a nicotinamide derivative and tiotropium or a derivative thereof, compositions containing it and the uses of, such a combination. The combination according to the present invention is useful in numerous diseases, disorders and conditions, in particular inflammatory, allergic and respiratory diseases, disorders and conditions.
    Type: Application
    Filed: February 6, 2003
    Publication date: November 27, 2003
    Inventors: Simon Bailey, Elisabeth C. L. Gautier, Alan J. Henderson, Thomas V. Magee, Anthony Marfat, John P. Mathias, Dale G. McLeod, Sandra M. Monaghan, Blanda L. C. Stammen
  • Nicotinamide derivatives useful as PDE4 inhibitors
    Publication number: 20030220366
    Abstract: The invention relates to nicotinamide derivatives and to processes for the preparation of, intermediates used in the preparation of, compositions containing and the uses of, such derivatives. The nicotinamide derivatives according to the present invention are useful in numerous diseases, disorders and conditions, in particular inflammatory, allergic, respiratory diseases, disorders and conditions, as well as wounds.
    Type: Application
    Filed: February 6, 2003
    Publication date: November 27, 2003
    Inventors: Simon Bailey, Elisabeth C. L. Gautier, Alan J. Henderson, Thomas V. Magee, Anthony Marfat, John P. Mathias, Dale G. McLeod, Sandra M. Monaghan, Blanda L. C. Stammen
  • Adenosine A2A receptor agonists as antiinflammatory agents
    Patent number: 6326359
    Abstract: The present invention provides compounds of formula (I): and pharmaceutically acceptable salts and solvates thereof, together with processes for the preparation of, compositions containing, uses of and intermediates used in the preparation of such compounds that have A2a receptor agonist activity.
    Type: Grant
    Filed: October 15, 1999
    Date of Patent: December 4, 2001
    Assignee: Pfizer Inc
    Inventors: Sandra M. Monaghan, Simon J. Mantell